scout
|Videos|November 28, 2016

The Best Therapy Option for a Patient With mCRPC

Raoul Concepcion, MD, director, Comprehensive Prostate Center, discussed the best treatment option for a patient with metasatic castration-resistant prostate cancer (mCRPC) during the LUGPA Annual Meeting.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME